Juvisé Pharmaceuticals

Private

VilleurbanneHealthcare & Life Scienceshttps://juvisepharmaceuticals.com/

Last Round

Debt

Feb 9, 2026

Total Funding Raised

$889M

Company Overview

Juvisé Pharmaceuticals is a specialty pharmaceutical company that acquires and markets essential medicines in therapeutic areas including oncology, cardiology, gastroenterology, and neuroscience.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

specialty pharmaceuticalspharmaceutical asset acquisitionlegacy drug commercializationpharma divestmentoncology medicinedrug lifecycle managementpharmaceutical supply chainpharmacovigilanceregulatory complianceasset-light pharmabranded genericspharma roll-upcontract manufacturingCMO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Juvisé Pharmaceuticals Comparables

Compare Juvisé Pharmaceuticals with similar companies based on industry and business-model similarity.

Juvisé Pharmaceuticals comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Pharmanovia	86%
CHEPLAPHARM Arzneimittel GmbH	85%
Essential Pharma	84%

View all Comparables

Juvisé Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Feb 9, 2026
Private Equity	Mar 26, 2024
Debt	Feb 4, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Emilie Gounon

COO - Directeur général

Executive Team

Juvisé Pharmaceuticals Investors

Notable investors and investment history

Juvisé Pharmaceuticals investors
Investor	Rounds
Hayfin Capital Management	Debt
Pemberton Asset Management	Private Equity
Bpifrance	Private Equity

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 11, 2025
Monthly visitors increased 53% MoM.
May 11, 2025
Grew 23% QoQ, from 71 to 87 employees.

View all signals

Juvisé Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Juvisé Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Juvisé Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersVilleurbanne

Employee Range111

Year Founded2008

Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.